vs
Aterian, Inc.（ATER）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
Aterian, Inc.的季度营收约是Protalix BioTherapeutics, Inc.的1.7倍（$15.1M vs $9.1M），Aterian, Inc.净利率更高（-52.5% vs -60.3%，领先7.8%），Aterian, Inc.同比增速更快（-38.5% vs -49.9%），Protalix BioTherapeutics, Inc.自由现金流更多（$1.6M vs $-1.0M），过去两年Protalix BioTherapeutics, Inc.的营收复合增速更高（-6.7% vs -13.5%）
Aterian, Inc.是一家技术驱动的消费品企业，依托人工智能与数据分析挖掘市场需求，开发、采购并销售家居、个护、健康、户外、宠物用品等多品类高性价比商品，主要通过全球主流电商平台销往北美、欧洲等核心市场。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
ATER vs PLX — 直观对比
营收规模更大
ATER
是对方的1.7倍
$9.1M
营收增速更快
ATER
高出11.4%
-49.9%
净利率更高
ATER
高出7.8%
-60.3%
自由现金流更多
PLX
多$2.7M
$-1.0M
两年增速更快
PLX
近两年复合增速
-13.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $15.1M | $9.1M |
| 净利润 | $-7.9M | $-5.5M |
| 毛利率 | 56.1% | 49.4% |
| 营业利润率 | -51.1% | -51.1% |
| 净利率 | -52.5% | -60.3% |
| 营收同比 | -38.5% | -49.9% |
| 净利润同比 | -512.2% | -184.8% |
| 每股收益（稀释后） | — | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATERPLX
| Q4 25 | $15.1M | $9.1M | ||
| Q3 25 | $19.0M | $17.9M | ||
| Q2 25 | $19.5M | $15.7M | ||
| Q1 25 | $15.4M | $10.1M | ||
| Q4 24 | $24.6M | $18.2M | ||
| Q3 24 | $26.2M | $18.0M | ||
| Q2 24 | $28.0M | $13.5M | ||
| Q1 24 | $20.2M | — |
净利润ATERPLX
| Q4 25 | $-7.9M | $-5.5M | ||
| Q3 25 | $-2.3M | $2.4M | ||
| Q2 25 | $-4.9M | $164.0K | ||
| Q1 25 | $-3.9M | $-3.6M | ||
| Q4 24 | $-1.3M | $6.5M | ||
| Q3 24 | $-1.8M | $3.2M | ||
| Q2 24 | $-3.6M | $-2.2M | ||
| Q1 24 | $-5.2M | — |
毛利率ATERPLX
| Q4 25 | 56.1% | 49.4% | ||
| Q3 25 | 56.1% | 53.4% | ||
| Q2 25 | 54.3% | 62.5% | ||
| Q1 25 | 61.4% | 19.1% | ||
| Q4 24 | 63.4% | 78.7% | ||
| Q3 24 | 60.3% | 53.4% | ||
| Q2 24 | 60.4% | 29.8% | ||
| Q1 24 | 65.1% | — |
营业利润率ATERPLX
| Q4 25 | -51.1% | -51.1% | ||
| Q3 25 | -10.7% | 11.9% | ||
| Q2 25 | -23.1% | 7.5% | ||
| Q1 25 | -24.1% | -41.0% | ||
| Q4 24 | -6.5% | 39.6% | ||
| Q3 24 | -6.6% | 22.2% | ||
| Q2 24 | -11.5% | -18.0% | ||
| Q1 24 | -26.1% | — |
净利率ATERPLX
| Q4 25 | -52.5% | -60.3% | ||
| Q3 25 | -12.0% | 13.2% | ||
| Q2 25 | -25.0% | 1.0% | ||
| Q1 25 | -25.4% | -35.8% | ||
| Q4 24 | -5.3% | 35.6% | ||
| Q3 24 | -6.8% | 18.0% | ||
| Q2 24 | -13.0% | -16.4% | ||
| Q1 24 | -25.5% | — |
每股收益（稀释后）ATERPLX
| Q4 25 | — | $-0.06 | ||
| Q3 25 | — | $0.03 | ||
| Q2 25 | — | $0.00 | ||
| Q1 25 | — | $-0.05 | ||
| Q4 24 | — | $0.10 | ||
| Q3 24 | — | $0.03 | ||
| Q2 24 | — | $-0.03 | ||
| Q1 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.9M | $14.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $15.2M | $48.2M |
| 总资产 | $29.6M | $82.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ATERPLX
| Q4 25 | $4.9M | $14.7M | ||
| Q3 25 | $7.6M | $13.6M | ||
| Q2 25 | $10.5M | $17.9M | ||
| Q1 25 | $14.3M | $19.5M | ||
| Q4 24 | $18.0M | $19.8M | ||
| Q3 24 | $16.1M | $27.4M | ||
| Q2 24 | $20.3M | $23.4M | ||
| Q1 24 | $17.5M | — |
股东权益ATERPLX
| Q4 25 | $15.2M | $48.2M | ||
| Q3 25 | $22.6M | $52.9M | ||
| Q2 25 | $24.3M | $49.9M | ||
| Q1 25 | $27.0M | $45.2M | ||
| Q4 24 | $30.0M | $43.2M | ||
| Q3 24 | $30.6M | $32.4M | ||
| Q2 24 | $30.9M | $28.6M | ||
| Q1 24 | $33.0M | — |
总资产ATERPLX
| Q4 25 | $29.6M | $82.3M | ||
| Q3 25 | $40.1M | $82.3M | ||
| Q2 25 | $45.4M | $78.5M | ||
| Q1 25 | $49.8M | $73.9M | ||
| Q4 24 | $49.5M | $73.4M | ||
| Q3 24 | $52.1M | $61.6M | ||
| Q2 24 | $59.9M | $91.5M | ||
| Q1 24 | $55.7M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.0M | $2.0M |
| 自由现金流经营现金流 - 资本支出 | $-1.0M | $1.6M |
| 自由现金流率自由现金流/营收 | -6.9% | 17.8% |
| 资本支出强度资本支出/营收 | 0.0% | 4.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-13.6M |
8季度趋势，按日历期对齐
经营现金流ATERPLX
| Q4 25 | $-1.0M | $2.0M | ||
| Q3 25 | $-1.6M | $-3.7M | ||
| Q2 25 | $-4.4M | $-5.2M | ||
| Q1 25 | $-3.9M | $-5.1M | ||
| Q4 24 | $-9.0K | $4.0M | ||
| Q3 24 | $-722.0K | $4.1M | ||
| Q2 24 | $2.9M | $-3.6M | ||
| Q1 24 | $-6.0K | — |
自由现金流ATERPLX
| Q4 25 | $-1.0M | $1.6M | ||
| Q3 25 | $-1.6M | $-4.2M | ||
| Q2 25 | $-4.4M | $-5.7M | ||
| Q1 25 | — | $-5.4M | ||
| Q4 24 | — | $3.6M | ||
| Q3 24 | — | $4.0M | ||
| Q2 24 | $2.9M | $-3.8M | ||
| Q1 24 | $-42.0K | — |
自由现金流率ATERPLX
| Q4 25 | -6.9% | 17.8% | ||
| Q3 25 | -8.4% | -23.7% | ||
| Q2 25 | -22.7% | -36.2% | ||
| Q1 25 | — | -53.0% | ||
| Q4 24 | — | 19.6% | ||
| Q3 24 | — | 22.4% | ||
| Q2 24 | 10.3% | -28.1% | ||
| Q1 24 | -0.2% | — |
资本支出强度ATERPLX
| Q4 25 | 0.0% | 4.4% | ||
| Q3 25 | 0.2% | 2.8% | ||
| Q2 25 | 0.0% | 2.8% | ||
| Q1 25 | 0.0% | 3.0% | ||
| Q4 24 | 0.0% | 2.3% | ||
| Q3 24 | 0.0% | 0.5% | ||
| Q2 24 | 0.0% | 1.3% | ||
| Q1 24 | 0.2% | — |
现金转化率ATERPLX
| Q4 25 | — | — | ||
| Q3 25 | — | -1.58× | ||
| Q2 25 | — | -31.91× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATER
| Sales Channel Directly To Consumer | $13.1M | 87% |
| Heating Cooling And Air Quality | $2.1M | 14% |
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
